Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study

被引:28
|
作者
Ljotsson, Brjann [1 ,2 ]
Jones, Michael [3 ]
Talley, Nicholas J. [4 ]
Kjellstrom, Lars [5 ]
Agreus, Lars [6 ]
Andreasson, Anna [3 ,7 ,8 ]
机构
[1] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Nobels Vag 9, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden
[3] Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia
[4] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia
[5] City Gastro Dept, Stockholm, Sweden
[6] Karolinska Inst, Care Sci & Soc, Div Family Med & Primary Care, Dept Neurobiol, Stockholm, Sweden
[7] Stockholm Univ, Stress Res Inst, Stockholm, Sweden
[8] Karolinska Inst, Div Clin Med, Dept Med Solna, Stockholm, Sweden
关键词
Irritable bowel syndrome; patient-reported outcomes; population study; psychometric evaluation; symptom severity; PATIENT-REPORTED OUTCOMES; EXPOSURE-BASED TREATMENT; HEALTH SURVEY SF-36; HYPNOTHERAPY; PREDICTORS; SYSTEM; IMPACT;
D O I
10.1177/2050640619900577
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome (GSRS-IBS) is a 13-item measure of IBS symptom severity. The scale has been used in several studies, but its psychometric properties have been insufficiently investigated and population-based data are not available. Objective The objective of this article is to establish the factor structure and discriminant and convergent validity of the GSRS-IBS. Methods The study was based on a Swedish population sample (the Popcol study), of which 1158 randomly selected participants provided data on the GSRS-IBS. We used confirmatory factor analysis (CFA) and compared total and subscales scores in different groups, including IBS diagnostic status, treatment-seeking behavior, and predominant bowel habits. The GSRS-IBS scores were also correlated with quality of life indexes. Results The sample included 164 participants with a confirmed Rome III IBS diagnosis and 994 participants without the disease. The CFA confirmed the subscales with one exception, in which the incomplete bowel-emptying item belonged to the constipation subscale rather than the diarrhea subscale. The GSRS-IBS total score and subscales were associated with diagnostic status, treatment-seeking behavior, and quality of life dimensions. The relevant subscales scores also differed between the diarrhea- and constipation-predominant subtypes of IBS. Conclusion The GSRS-IBS total score and subscales have high discriminant and convergent validity. The CFA confirmed the overall validity of the subscales but suggest that a sense of incomplete emptying belongs to the constipation rather than the diarrhea symptom cluster. We conclude that the GSRS-IBS is an excellent measure of IBS symptom severity in the general population.
引用
收藏
页码:284 / 292
页数:9
相关论文
共 50 条
  • [41] The IBS-36: A new quality of life measure for irritable bowel syndrome
    Groll, D
    Vanner, SJ
    Depew, T
    DaCosta, LR
    Simon, JB
    Groll, A
    Roblin, N
    Paterson, WG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (04): : 962 - 971
  • [42] The role of mood in irritable bowel syndrome symptom severity and quality of life
    Hauser, G.
    Pletikosic, S.
    Tkalcic, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 69 - 69
  • [43] The role of mood in irritable bowel syndrome symptom severity and the quality of life
    Pletikosic, S.
    Tkalcic, M.
    Hauser, G.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 618 - 618
  • [44] DEPRESSION, NOT ANXIETY, PREDICTS EXTRAINTESTINAL SYMPTOM SEVERITY IN IRRITABLE BOWEL SYNDROME
    Hassan, Rafla
    Ballou, Sarah
    Yu, Vanessa
    Rangan, Vikram
    Nee, Judy
    Iturrino, Johanna
    Kaptchuk, Ted J.
    Lembo, Anthony
    GASTROENTEROLOGY, 2021, 160 (06) : S679 - S680
  • [45] Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
    Anna Lyra
    Markku Hillil?
    Teppo Huttunen
    Sofia M?nnikk?
    Mikko Taalikka
    Julia Tennil?
    Anneli Tarpila
    Sampo Lahtinen
    Arthur C Ouwehand
    Lea Veijola
    World Journal of Gastroenterology, 2016, (48) : 10631 - 10642
  • [46] Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome
    van der Veek, Patrick P. J.
    Van Rood, Yanda R.
    Masclee, Ad A. M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (03) : 321 - 328
  • [47] CHRONOTYPE AND IRRITABLE BOWEL SYNDROME: IMPACT OF CIRCADIAN CLOCK ON SYMPTOM SEVERITY
    Strzepka, Jessica
    Zilberstein, Netanel
    Biglin, Mary
    Eganhouse, Matthew
    Sanzo, Gabriella
    Swanson, Garth
    GASTROENTEROLOGY, 2022, 162 (07) : S758 - S758
  • [48] Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
    Lyra, Anna
    Hillila, Markku
    Huttunen, Teppo
    Mannikko, Sofia
    Taalikka, Mikko
    Tennila, Julia
    Tarpila, Anneli
    Lahtinen, Sampo
    Ouwehand, Arthur C.
    Veijola, Lea
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (48) : 10631 - 10642
  • [49] Association between immune markers and symptom severity in Irritable bowel syndrome
    Polster, A.
    Bennet, S.
    Ohman, L.
    Tornblom, H.
    Simren, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 92 - 92
  • [50] Altered rectal perception in irritable bowel syndrome is associated with symptom severity
    Posserud, Iris
    Syrous, Alma
    Lindstrom, Lina
    Tack, Jan
    Abrahamsson, Hasse
    Simren, Magnus
    GASTROENTEROLOGY, 2007, 133 (04) : 1113 - 1123